Hydrogen Water & Rheumatoid Arthritis: What the 2012 Ishibashi Pilot Study Found

Quick answer

In a small 2012 open-label pilot (Ishibashi et al., Medical Gas Research), 20 people with rheumatoid arthritis drank high-hydrogen water for eight weeks. A marker of oxidative stress dropped and disease-activity scores fell — and every one of the five early-stage patients reached remission. It's an encouraging early signal, not proof: there was no control group.

What the study did

Twenty patients with rheumatoid arthritis (RA) drank 530 mL of water containing 4–5 ppm of molecular hydrogen every day for four weeks, took a four-week washout, then drank it for another four weeks. At the end of each period the researchers measured two things:

• Urinary 8-OHdG — a standard marker of oxidative (free-radical) stress.
• DAS28 (CRP) — the standard composite score for RA disease activity.

The rationale: the hydroxyl radical is implicated in RA, and molecular hydrogen acts as a selective scavenger for that radical.

What it found

• Urinary 8-OHdG fell by an average of 14.3% (p < 0.01).
• DAS28 dropped from 3.83 to 3.02 in the first drinking period (p < 0.01), and from 2.83 to 2.26 in the second (p < 0.01).
• All 5 patients with early RA (duration under 12 months, ACPA-negative) achieved remission; 4 became symptom-free by the study's end.

What this means for you

These results suggest hydrogen-rich water may help lower oxidative stress and support lower disease activity alongside conventional RA care — the authors framed it as complementing standard therapy, not replacing it.

The caveats matter, and we won't hide them: this was a small (n = 20), open-label pilot with no control group, so the improvement can't be cleanly separated from placebo or the natural ups and downs of RA. It's a reason to run a proper randomized trial — not a reason to change your treatment. Talk to your rheumatologist before adding anything to your regimen.